Stereotactic neural transplantation

Stereotactic and Functional Neurosurgery

Volumn 62, Issue 1-4, 1994, Pages 120-133

  Hitchcock, E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Fetal tissue; Movement disorder; Neural; Parkinson s disease; Transplantation

Indexed keywords

ANIMAL TISSUE; CONFERENCE PAPER; FETUS; HUMAN; HUMAN TISSUE; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; STEREOTAXIC SURGERY;

ADRENAL MEDULLA; BRAIN TISSUE TRANSPLANTATION; CLINICAL TRIALS; FETAL TISSUE TRANSPLANTATION; HISTORY OF MEDICINE, 19TH CENT.; HISTORY OF MEDICINE, 20TH CENT.; HUMAN; MOVEMENT DISORDERS; PARKINSON DISEASE; STEREOTAXIC TECHNIQUES;

EID: 0028619005     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000098607     Document Type: Article

References (72)

1. Bankicwicz K. Plunkett R, Kopin I, ct al: Transient behavioural recovery in hemiparkinsonian primates after adrenal medullary allografts; in Gash DM, Sladek JR Jr (eds): Transplantation into the Mammalian CNS: Progress in Brain Research. Amsterdam, Elsevier Science, 1993, vol 78, pp 543-550.
2. Brooks-Eidelberg B, Eidelberg E, Story J, et al: Adrenal autotransplant in behaviorally trained MPTP-treated monkeys. Soc Neurosci Abstr 1988; 157:6.
3. Date I, Felton S, Felten D: The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogenic or xenogeneic graft. Brain Res 1991;545:191-198.
4. Morihisa J, Nakamura R, Freed W, ct al: Adrenal medullary grafts survive and exhibit catecholamine-specific fluorescence in the primate brain. Exp Neurol 1984;84:643-653.
5. Hansen J, Bing G, Nottcr M, et al: Adrenal chromaffin cells as transplant in animal models of Parkinson’s disease. J Electron MicroscTech 1989;12:308-315.
6. Hansen J, Kordower J, Fiandaca M, et al: Adrenal medullary autografts into the basal ganglia of cebus monkeys: Graft viability and fine structure. Exp Neurol 1988;102:65-67.
7. Gash D, Kordower J, Fiandaca M, et al: Adrenal medullary transplants in primates; in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, pp 15-25.
8. Freed W, Morihisa J, Spoor E, et al: Transplanted adrenal chromaffin cells in rat brain reduces lesion induced rotational behaviour. Nature 1981;292:351-352.
9. Bakay R: What have we learned from primate research?; in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, pp 53-66.
10. Dohan F, Robertson J, Feler C, et al: Autopsy findings in a Parkinson’s disease patient treated with adrenal medullary to caudate nucleus tranplant. Soc Neurosci Abstr 1988; 14:8.
11. Peterson D, Price M, Small C: Autopsy findings in a patient who had adrenal-to-brain transplant for Parkinson’s disease. Neurology 1989;39:235-238.
12. Hirsch E, Duyckaerts C, Javoy-Agid F, et al: Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson’s disease? Ann Neurol 1990;27:676-682.
13. Hurtig H, Joyce J, Sladek J, et al: Post-mortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson’s disease. Ann Neurol 1989;25:607-614.
14. Backlund E, Granberg P, Hamberger B, et al: Transplantation of adrenal medullary tissue to striatum in parkinsonism. J Neurosurg 1985;62:169-173.
15. Backlund E, Forde E, ct al: Transplantation in Parkinson’s disease: Two cases of adrenal medullary grafts to the putamen. Ann Neurol 1987;22:457-468.
16. Takcuchi J, Takcbe Y, Sakakura T, et al: Adrenal medulla transplantation into the putamen in Parkinson’s disease. Neurosurgery 1990, 26:499-503.
17. Madrazo I, Drucker-Colin R, Diaz V, et al: Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N Engl J Med 1987, 316: 831-834.
18. Allen G, Burns R, Tulipan N, et al: Adrenal medullary transplantation to the caudate nucleus in Parkinson’s disease. Initial clinical results in 18 patients. Arch Neurol 1989;46:487—491.
19. Backlund E, Granberg P, Hamberger B, et al: Transplantation of adrenal medullary tissue to striatum in parkinsonism. J Neurosurg 1985;62:169-173.
20. Goetz C, Olanow C, Koller W, et al: Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson’s disease. N Engl J Med 1989;320: 337-341.
21. Lieberman A, Ransohoff J, Berezeller P, Goldstein M: Adrenal medullary transplants as a treatment for advanced Parkinson’s disease. Prog Brain Res 1990;82:665-669.
22. Lindvall O, Backlund E, Farde L, et al: Transplantation in Parkinson’s disease: Two cases of adrenal medullary grafts to the putamen. Ann Neurol 1987;22:457-468.
23. Penn R, Goetz C, Tanner C, et al: The adrenal medullary transplant operations for Parkinon’s disease: Clinical observations in five patients. Neurosurgery 1988;22:999-1004.
24. Jioa S, Zhang W, Cao J, et al: Study of adrenal medullary tissue transplantation into striatum in parkinsonism; in Gash DM, Sladck JR Jr (eds): Transplantation into the Mammalian CNS: Progress in Brain Research. Amsterdam, Elsevier, Science, 1988. vol 78, pp 575-580.
25. Lopez-Lozano JJ, Brcta B, Abuscal J, et al: CPH neural transplantation group. Preparation of adrenal medullary tissue for transplantation in Parkinson’s disease. A new procedure. J Neurosurg 1989; 71:452-454.
26. Lopez-Lozano JJ, Brera B, Abuscal J, et al: A one-year follow-up of autotransplants of perfused adrenal medulla into Parkinson’s patients; in Dunnett SB. Richards S J (eds): Progress in Brain Research. Amsterdam, Elsevier, 1990, vol 83, pp 653-663.
27. Lopez-Lozano J, Bravo G, Brera B, et al: Can an analogy be drawn between clinical evolution of Parkinson’s patients who undergo autoimplantation of adrenal medulla and those of fetal ventral mesencephalon: in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, pp 87-98.
28. Olanow C, Koller W, Goetz C, et al: Autologous transplantation of adrenal medulla in Parkinson’s disease: 18-month results. Arch Neurol 1990;47:1286-1289.
29. Tanner CM, Goetz CG., Gilley DW, et al: Behavioural aspects of intrastriatal adrenal medulla transplant surgery in Parkinson’s disease. Neurology 1988;38:143.
30. Penn R, Goetz C, Tanner C, et al: The adrenal medullary transplant operations for Parkinson’s disease: Clinical observations in five patients. Neurosurgery 1988;22:999-1004.
31. Goetz C, Stebbins G, Klawans H. et al: United Parkinson Foundation Ncurotransplantation Registry. Multicenter US and Canadian Database: Presurgical and 12 month follow-up; in Dunnett SB. Richards R (eds): Neural Transplantation: From Molecular Basis to Clinical Application. Amsterdam, Elsevier, 1993.
32. Bakay R, Allen G, Apuzzo M, et al: Preliminary report on adrenal medullary grafting from the American Association of Neurological Surgeons graft project; in Dunnett SB, Richards SR (eds): Neural Transplantation: From Molecular Basis to Clinical Application. Amsterdam, Elsevier, 1989.
33. Goetz C, Tanner C, Penn R, et al: Adrenal medullary transplant to the striatum of patients with advanced Parkinson’s disease: 1-year motor and psychomotor data. Neurology 1990;40:273-276.
34. Hurtig H, Joyce J, Sladek J, et al: Post-mortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson’s disease. Ann Neurol 1989;25:607-614.
35. Waters C, Itabash HH, Apuzzo MU, et al: Adrenal to caudate transplantation - post-mortem study. Mov Disord 1990;5:248-250.
36. Kordower JH, Cochran E, Penn R, et al: Putative chromaffin cell survival and enhanced host derived TH-fibcr innervation following a functional adrenal medulla autograft for Parkinsons’s disease. Ann Neurol 1991;29:405-412.
37. Jiang N, Jiang C, Tang Z, et al: Human foetal brain transplant trials in the treatment of parkinsonism. Acta Acad Med Shanghai 1987;14:1.
38. Madrazo I, Leon V, Torres C, et al: Transplantation of foetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease, (letter). N Engl J Med 1988:318: 51.
39. Madrazo I, Franco-Bourland R, Aguilera H, et al: Open microsurgery for human brain transplantation. Experience in the treatment of Parkinsons’s disease; in Lindvall O, Bjorklund A, Widner H, (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, vol 14, pp 153-162.
40. Lindvall O, Rehncrona S, Brundin P, et al: Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease: A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-631.
41. Lindvall O: Intracerebral transplantation of fetal dopamine neurones in Sweden: Clinical experience from four patients with idiopathic Parkinson’s disease; in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, pp 111-122.
42. Molina H, Quinones R, Lazaro A, et al: Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson’s disease: The Cuban experience; in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, pp 99-110.
43. Hitchcock E, Clough C, Hughes R, et al: Transplantation in Parkinson’s disease: Stereotactic implantation of adrenal medulla and foetal mesencephalon. Acta Neurochir Suppl 1988:46:48-50.
44. Hitchcock ER, Kenny BG, et al: Stereotactic implantation of foetal mesencephalon (STIM): The UK. experience. Prog Brain Res 1990:82:723-728.
45. Detta A, et al: Phcnotypic plasticity of‘mature’ human foetal mesencephalic dopaminergic neurons and glial cells. Restor Neurol Ncurosci 1992:4:41-46.
46. Jiang N, Jiang C, Tang Z, et al: Human foetal brain transplant trials in the treatment of parkinsonism. Acta Acad Med Shanghai 1987; 14:1.
47. Lopez-Lozano J, Bravo G, Brera B, et al: Can an analogy be drawn between clinical evolution of Parkinson’s patients who undergo auto-implantation of adrenal medulla and those of fetal ventral mesencephalon; in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, pp 87-98.
48. Madrazo I., Franco-Bourland R, Aguilera H, et al: Open microsurgery for human brain transplantation. Experience in the treatment of Parkinson’s disease; in Lindvall O. Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Amsterdam, Elsevier Science, 1991, vol 14, pp 153-162.
49. Madrazo I, Franco-Bourland R, Ostrosky-Solis F, et al: Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects. Arch Neurol 1990;47:1281-1285.
50. Madrazo I, Leon V, Torres C. et al: Transplantation of foetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease (letter). N Engl J Med 1988, 318: 51.
51. Detta A, Hitchcock E: The selective viabilitiy of human foetal brain cells. Brain Res 1990;520: 277-283.
52. Dong JF, Detta A, Hitchcock ER: Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons. In press.
53. Simmonds GR, Freed WJ: Effects of intravcntricular substantia nigra allografts as a function of donor age. Brain Res 1990;530:12-90.
54. Bjorklund A, Steveni U, Dunnett S, et al: Cross species neural grafting in a rat model of Parkinson’s disease. Nature 1982;298:652-654.
55. Brundin P, Isacson O, Gage FH, et al: Intracerebral grafts of neuronal cell suspensions: in Bjorklund A, Stenevi U (eds): Neuronal Grafting in the Mammalian CNS. Amsterdam, Elsevier, 1985, chap 6, pp51-59.
56. Dymecki J, Poltorak M, Freed WJ: The degree of genetic disparity between donor and host correlates with survival of intravcntricular substantia nigra grafts. Reg Immunol 1990;3:17-22.
57. Sladek J, Collier T. Haber S, et al: Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 1986;17:809-818.
58. Sladek J., Redmond D, Collier T, et al: Fetal dopamine neural grafts: Extended reversal of methyl- phenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 1988;78:497-506.
59. Henderson BTH, Kenny BG, Hitchcock ER, et al: A comparative evaluation of clinical rating scales and quantitative measurements in assessment of pre-and poststriatal implantation of human foetal mcscnccphalon in Parkinson’s disease. Acta Neurochir Suppl 1991:48-50.
60. CAPIT Committee, Langston JW, Widner H, et al: Committee report. Mov Disord 1992;7:2-13.
61. Rose FD, Johnson DA: Neural Implants and Recovery of Function: Human Work. Recovery from Brain Damage. New York, Plenum Press, 1992.
62. Freed C, Breeze R, Rosenberg N, et al: Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N Engl J Med 1992; 327:1549-1555.
63. Spencer D, Robbins R. Naftolin F, ct al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N Engl J Med 1992;327:1541-1548.
64. Widner H, Tetrud J, Rehncrona S, et al: Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by l-mcthyl-4-phenyl-l, 2, 3, b-tetrahydropyridine (MPTP). N Engl J Med 1992;327:1556-1563.
65. Lindvall O, Rehncrona S, Brundin P, et al: Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease: A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989, 46:615-631.
66. Sawle G, Bloomfield P, Bjorklund A. et al: Transplantation of fetal dopamine neurons in Parkinson’s disease: PET [l8F]6-l-fiuorodopa studies in two patients with putaminal implants. Ann Neurol 1992;31:166-173.
67. Freed C, Breeze R, Rosenberg N, et al: Transplantation of human fetal dopamine cells for Parkinson’s disease: Results at one year. Arch Neurol 1990;47:505-512.
68. Redmond DF, Lcranth C, Spencer DD, et al: Fetal neural graft survival. Lancet 1990, 336:820-822.
69. Bankiewiez KS, Whitwell HL, Sofroniew MV, et al: Survival of TH-positivc cells and graft-induced host dopaminergic sprouting in patients with Parkinson’s disease after intrastriatal grafting of fetal ventral mesencephalon. In press.
70. Dong JF, Detta A, Hitchcock ER: Susceptibility of human foetal brain tissue to cool and freeze storage. Brain Res 1993;621:242-248.
71. Dong JF, Detta A, Bakker MHM, Hitchcock ER: Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurones. Neuroscience 1993;56/l:53-60.
72. Hitchcock ER: Neural transplantation in degenerative disease. Molecular genetics in medicine; in Roberts DF, Chester R (eds): Proceedings of the 26th Annual Symposium of the Galton Institute, London, 1989, chap 8, pp 97-123.